Session information

Tweet

Medical Seminar

[MeS13] Medical Seminar 13　How will the front-line treatment change in ALK positive lung cancer??

Fri. Feb 18, 2022 12:25 PM - 1:15 PM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair：Miyako Satouchi（Department of Thoracic Oncology, Hyogo Cancer Center）

Sponsored by Pfizer Japan Inc.

+Add all to schedule

[MeS13-1] Reconsidering, What the evidence of first-line treatment in ALK（+） lung cancer is...

^○Naoyuki Nogami (Department of Community Medicine, Pulmonology and Cardiology, Ehime University Graduate School of Medicine)

[MeS13-2] Optimal treatment strategy considered subsequent therapies in ALK（+） lung cancer

^○Motohiro Tamiya (Thoracic Oncology, Osaka International Cancer Institute)